Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-25-267111
Filing Date
2025-11-05
Accepted
2025-11-05 16:41:55
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3/A resale_s-3a_2025_-_no_xb.htm S-3/A 433051
2 EX-23.1 bioa-ex23_1.htm EX-23.1 2775
3 GRAPHIC img129755914_0.jpg GRAPHIC 6970
4 GRAPHIC img129755914_1.jpg GRAPHIC 6970
  Complete submission text file 0001193125-25-267111.txt   456351
Mailing Address 5885 HOLLIS STREET SUITE 370 EMERYVILLE CA 94608
Business Address 5885 HOLLIS STREET SUITE 370 EMERYVILLE CA 94608 510-806-1445
BioAge Labs, Inc. (Filer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-290690 | Film No.: 251454738
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)